Business Context and Reporting Period
This Form 8-K, dated August 6, 2026, reports on Silicon Valley Acquisition Corp. (SVAQ), a Cayman Islands exempted company and emerging growth company. The filing details amendments to the Business Combination Agreement and Sponsor Support Agreement originally executed on June 17, 2026, regarding the proposed merger with EigenQ, Inc. Upon closing, SVAQ will domesticate as a Delaware corporation, and the combined entity will be known as PubCo.
Key Financial Metrics
This filing is a current report regarding material definitive agreements and does not contain audited financial statements, revenue, profit, cash flow, or debt metrics for the reporting period. The filing references the following financial terms related to the transaction structure:
- Warrant Exercise Price: $11.50 per share.
- Equity Incentive Plan Reserve: Approximately 10% of the issued and outstanding shares of PubCo Common Stock on a fully-diluted basis immediately after closing.
- Transaction Financing Support Shares: Up to 2,165,950 SVAQ Class B ordinary shares set aside by the Sponsor.
Material Changes Versus Prior Period
The filing outlines specific amendments to the transaction agreements effective August 6, 2026:
- Share Transfer Flexibility: Clarified that Transaction Support Shares may be transferred for any purpose related to the Business Combination, not solely for incentivizing Transaction Financing.
- Redemption Timing: Confirmed that SVAQ will redeem Class A ordinary shares tendered by public shareholders immediately before the Domestication.
- Board Composition: Expanded the size of the PubCo board of directors from 7 members to 9 members.
- Equity Plan: Defined the initial share reserve for the PubCo equity incentive plan at approximately 10% of post-closing fully-diluted shares.
Guidance, Outlook, and Risks
Outlook and Process: The Business Combination is subject to shareholder approval. A Registration Statement containing a proxy statement/prospectus is expected to be filed with the SEC. The filing explicitly states it is not an offer to sell securities or a solicitation of proxies.
Risks and Contingencies: The filing includes extensive forward-looking statements subject to numerous risks, including:
- Failure to obtain shareholder approval or satisfy closing conditions.
- Disruption of EigenQ's current operations.
- Political, social, or economic instability in emerging markets, specifically the Middle East.
- Risks related to quantum security infrastructure mandates and product commercialization.
- Supply chain risks and intellectual property infringement claims.
- Volatility in economic conditions and competitive pressures.
Investor Verification Checklist
- Verify the final terms of the Business Combination in the upcoming definitive proxy statement/prospectus.
- Confirm the exact number of shares to be redeemed by public shareholders prior to domestication.
- Review the full text of the First Amendment to the Business Combination Agreement (Exhibit 2.1) and Sponsor Support Agreement (Exhibit 10.1).
- Assess the impact of the expanded 9-member board on corporate governance.
- Monitor the status of the Registration Statement filing and SEC effectiveness declaration.